These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20444884)

  • 41. An overlapping binding site in the CYP7A1 promoter allows activation of FXR to override the stimulation by LXRalpha.
    Shang Q; Pan L; Saumoy M; Chiang JY; Tint GS; Salen G; Xu G
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G817-23. PubMed ID: 17690173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pioneer Factor Foxa2 Mediates Chromatin Conformation Changes for Activation of Bile Acid Targets of FXR.
    Hao Y; Han L; Wu A; Bochkis IM
    Cell Mol Gastroenterol Hepatol; 2024; 17(2):237-249. PubMed ID: 37879405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.
    Shimamoto Y; Ishida J; Yamagata K; Saito T; Kato H; Matsuoka T; Hirota K; Daitoku H; Nangaku M; Yamagata K; Fujii H; Takeda J; Fukamizu A
    J Biol Chem; 2004 Feb; 279(9):7770-6. PubMed ID: 14672953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs.
    Ramos Pittol JM; Milona A; Morris I; Willemsen ECL; van der Veen SW; Kalkhoven E; van Mil SWC
    Gastroenterology; 2020 Nov; 159(5):1853-1865.e10. PubMed ID: 32712104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury.
    Wei S; Wang R; Chen L; Jing M; Li H; Zheng R; Zhu Y; Zhao Y
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1134-1144. PubMed ID: 38615196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
    Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
    J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide binding and transcriptome analysis of human farnesoid X receptor in primary human hepatocytes.
    Zhan L; Liu HX; Fang Y; Kong B; He Y; Zhong XB; Fang J; Wan YJ; Guo GL
    PLoS One; 2014; 9(9):e105930. PubMed ID: 25198545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
    Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
    J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
    Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
    J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding.
    Kim JY; Kim HJ; Kim KT; Park YY; Seong HA; Park KC; Lee IK; Ha H; Shong M; Park SC; Choi HS
    Mol Endocrinol; 2004 Dec; 18(12):2880-94. PubMed ID: 15358835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.
    Renga B; Mencarelli A; Migliorati M; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
    Inflamm Res; 2011 Jun; 60(6):577-87. PubMed ID: 21279417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis.
    Anakk S; Watanabe M; Ochsner SA; McKenna NJ; Finegold MJ; Moore DD
    J Clin Invest; 2011 Jan; 121(1):86-95. PubMed ID: 21123943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
    Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
    Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
    Li T; Chiang JY
    Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.
    Fang S; Tsang S; Jones R; Ponugoti B; Yoon H; Wu SY; Chiang CM; Willson TM; Kemper JK
    J Biol Chem; 2008 Dec; 283(50):35086-95. PubMed ID: 18842595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells.
    He F; Li J; Mu Y; Kuruba R; Ma Z; Wilson A; Alber S; Jiang Y; Stevens T; Watkins S; Pitt B; Xie W; Li S
    Circ Res; 2006 Feb; 98(2):192-9. PubMed ID: 16357303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver.
    Mathur B; Shajahan A; Arif W; Chen Q; Hand NJ; Abramowitz LK; Schoonjans K; Rader DJ; Kalsotra A; Hanover JA; Azadi P; Anakk S
    Sci Adv; 2021 Apr; 7(17):. PubMed ID: 33883138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.